Preparation of Controlled-Release Fine Particles Using a Dry Coating Method

AAPS PharmSciTech
Shohei NakamuraHiroshi Yuasa

Abstract

Wet coating methods use organic solvents to prepare layered particles that provide controlled-release medications. However, this approach has disadvantages in that it can cause particle agglomeration, reduce pharmaceutical stability, and leave residual organic solvents. We used a dry coating method to overcome these issues. Fine particles (less than 50 μm in diameter) of controlled-release theophylline were created using theophylline (TP; model drug), polyethylene glycol 20,000 (PEG; drug fixative), hydrogenated castor oil (HCO; controlled-release material), hydrogenated rapeseed oil (HRSO; controlled-release material), and cornstarch (CS; core particle). An ultrahigh-speed mixer was employed to mix TP and CS for 5 min at 28,000 rpm. Subsequent addition of PEG produced single-core particles with a drug reservoir coating. Addition of HCO and HRSO to these particles produced a controlled-release layer on their surface, resulting in less than 10% TP dissolution after 8 h. We successfully demonstrated that this dry coating method could be used to coat 16-μm CS particles with a drug reservoir layer and a controlled-release layer, producing multi-layer coated single-core particles that were less than 50 μm in diameter. These can be u...Continue Reading

References

Apr 9, 1999·Drug Development and Industrial Pharmacy·Y MiyagawaH Sunada
Sep 19, 2002·Chemical & Pharmaceutical Bulletin·Norihito ShimonoYasuhiko Nakamura
Jan 17, 2004·Pharmaceutical Research·Nantharat Pearnchob, Roland Bodmeier
Aug 23, 2005·Physiology & Behavior·Lina EngelenFrits Bosman
Apr 20, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Mine OzyaziciGökhan Ertan
Dec 25, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·Pallab Roy, Aliasgar Shahiwala
Jun 3, 2009·International Journal of Pharmaceutics·James KowalskiAbu T M Serajuddin
Jan 17, 2012·Journal of Advanced Pharmaceutical Technology & Research·Ved ParkashVikas Jogpal
Feb 24, 2012·Drug Development and Industrial Pharmacy·Gopi M VenkateshJin-Wang Lai
Feb 15, 2015·International Journal of Pharmaceutics·Shin-Ichiro KimuraNoriyuki Namiki

❮ Previous
Next ❯

Citations

Jun 22, 2017·International Journal of Pharmaceutics·Toshiyuki NiwaKeita Kondo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nan fang yi ke da xue xue bao = Journal of Southern Medical University
Lin YaoJia-Bo Luo
A Medicina contemporânea
C S da ARAUJO
Canadian Anaesthetists' Society Journal
M J DiamondY S Brownstone
© 2022 Meta ULC. All rights reserved